HOME >> MEDICINE >> NEWS
More patients would refuse treatment if the outcome were impaired quality of life

New Haven, Conn. More patients would refuse life-sustaining treatment if they knew the outcome would be a life of severe functional or cognitive impairment, according to a study by a Yale researcher published Thursday in the New England Journal of Medicine.

"A central component of quality end of life care is honoring patients preferences," said Terri Fried, M.D., associate professor of internal medicine and geriatrics at Yale School of Medicine and lead author of the article. "If patients preferences are to be honored, they must be well understood. The results of this study suggest that this understanding depends upon an assessment of patients valuations of treatment burdens in relationship to the likelihood of different potential treatment outcomes. Outcomes of functional and cognitive impairment are particularly important to patients preferences, and require explicit consideration in advance care planning."

Studies examining the outcome of mortality demonstrate that its likelihood also affects preferences, but other outcomes have not been similarly examined. The objective of the current study was to examine the effect of treatment burden, a variety of treatment outcomes, and the likelihood of those outcomes on older seriously ill patients preferences for care.

The study included 226 persons 60 years of age or older with a limited life expectancy because of cancer, congestive heart failure, or chronic obstructive pulmonary disease. The participants were asked if they would want to receive a given treatment, first when the outcome was known with certainty, and then with different likely outcomes. The outcome without treatment was specified as dying of the underlying disease.

When the participants were told they could expect low burden treatment with a return to current health, 98.7 percent chose to receive treatment rather than die without it. When the treatment was changed to high burden, 11.2 percent of the 223 participants who
'"/>

Contact: Jacqueline Weaver
jacqueline.weaver@yale.edu
203-432-8555
Yale University
3-Apr-2002


Page: 1 2 3

Related medicine news :

1. Hormonal treatment improves survival in high-risk prostate cancer patients
2. Study finds that coordinating care of chronically ill patients does not increase liability
3. Mouse model reveals potential way to reduce cardiac deaths in kidney patients
4. Optical technique identifies vulnerable plaques in cardiac patients
5. NHS target driven culture is failing patients
6. Cardiac deaths peak in sleep hours for patients with sleep apnea
7. Chronic fatigue patients show lower response to placebos
8. Depression linked to insomnia in HIV patients
9. Disfigured patients may be forced to forego surgery
10. Massive weight loss patients create mass appeal for body contouring procedures
11. Drug therapy may be comparable to invasive cardiac procedures for elderly patients with heart attack

Post Your Comments:
(Date:8/30/2015)... Fl (PRWEB) , ... August 30, 2015 , ... Natural ... have beneficial effects as sleep aids and calming remedies, which help to improve mood ... result of a great deal of research in the field of regenerative medicine conducted ...
(Date:8/29/2015)... ... August 30, 2015 , ... Rio Salado College ... serve as the college’s Vice President of Strategic Initiatives and Information Services. O’Shea, who ... help the college expand its reach and impact through innovative technologies and strategies. , ...
(Date:8/29/2015)... , ... August 29, 2015 , ... ... insufficient scrotal support and protection against dribbled urine and sweat. "In order to ... Hills, N.Y. , The EASY ACCESS DRYNESS ENHANCED MEN'S UNDERGARMENT provides optimal support ...
(Date:8/29/2015)... ... August 29, 2015 , ... ProDrop Particles includes over ... preset contains 15 seconds of unique footage that users can shrink and stretch in ... attract and more. Users can customize color, brightness, scale, speed, range, and flare attributes ...
(Date:8/28/2015)... (PRWEB) , ... August 29, 2015 , ... Rio ... higher learning and the student experience as part of the EDUCAUSE - Next Generation ... Foundation . , This is the third Breakthrough Models Incubator hosted by ...
Breaking Medicine News(10 mins):Health News:Creative Medical Health’s Natural Rest® Now Available on ReCreative Medical Health’s Natural Rest® Now Available on RevNutrition.com 2Health News:Rio Salado College Appoints New Vice President of Strategic Initiatives and Information Services 2Health News:Modified Men’s Underwear Promote More Comfort and Hygiene - Designed by InventHelp Client (LGI-1968) 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 3Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 4
(Date:8/28/2015)... Research and Markets ( http://www.researchandmarkets.com/research/686gwf/investigation ) ... on China,s Bevacizumab Market ,2010-2019" report to their ... name of Avastin, bevacizumab injection is the first angiogenesis ... approved by CFDA to treat metastatic colorectal cancer. Currently, ... all come from Roche and its subsidiary Genectech. In ...
(Date:8/28/2015)... 2015 Patterson Medical, formerly the medical ... ), is now an independent company with today,s ... Medical by Madison Dearborn Partners (MDP).  ... a transition period before rebranding as the world,s ... products.  With the focused resources and expertise of ...
(Date:8/28/2015)... 2015 Research and Markets ... "Investigation Report on China,s Ranibizumab Market, 2012-2019" ... ranibizumab was approved by CFDA to treat wet age- ... a product of Novartis, is available in the Chinese ... developed drug for the treatment of wet AMD in ...
Breaking Medicine Technology:Investigation Report on China's Bevacizumab Market 2015-2019 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 3Investigation Report on China's Ranibizumab Market, 2012-2019 2
Cached News: